Symposia: Chronic Lymphocytic Leukemias: Basic and Translational
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Lymphoid Leukemias, adult, Antibody Therapy, apoptosis, Translational Research, CLL, Lymphomas, genomics, B Cell lymphoma, Combination therapy, Diseases, immune mechanism, immunology, Therapies, aggressive lymphoma, Lymphoid Malignancies, metabolism, Biological Processes, molecular biology, Technology and Procedures, gene editing, Study Population, Human, pathogenesis, Animal model, omics technologies
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Lymphoid Leukemias, adult, Antibody Therapy, apoptosis, Translational Research, CLL, Lymphomas, genomics, B Cell lymphoma, Combination therapy, Diseases, immune mechanism, immunology, Therapies, aggressive lymphoma, Lymphoid Malignancies, metabolism, Biological Processes, molecular biology, Technology and Procedures, gene editing, Study Population, Human, pathogenesis, Animal model, omics technologies
Sunday, December 11, 2022: 4:30 PM-6:00 PM
R02-R05
(Ernest N. Morial Convention Center)
Moderators:
Tanja Nicole Hartmann, PhD, Medical Center and Faculty of Medicine, University of Freiburg
and
Marek Mraz, MD, ARRAY(0xefd2d20)
Disclosures:
Hartmann: AstraZeneca: Research Funding.
4:30 PM
4:45 PM
5:00 PM
5:15 PM
5:30 PM
5:45 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH